Medications with hyperkalemic effects–spironolactone, amiloride, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin II receptor blockers (ARBs) were involved in DDIs that were associated with laboratory deviations (hyperkalemia). Here, ACE is linked to Hyperkalemia.